Insights from BCC Research

2017 Reflections: Emergence of the Digital Fabric

Posted by Michael Sullivan on Jan 17, 2018 12:30:00 PM

Michael, Editorial.pngIn 2017, the IT industry advanced deeper into the journey of creating a pervasive digital fabric that layers increasing technology enablers across nearly every facet of business. The surprising part is that this new landscape is just in the beginning stages. 2017 will be remembered as the year the Internet of Things (IoT), artificial intelligence (AI) and virtual reality (VR) edged closer to mainstream adoption across industry and society.

Read More

Topics: Information Technology

Market for Enzyme Inhibitors Faces Generic Competition, Payer Pushback

Posted by Laurie L. Sullivan on Jan 16, 2018 10:00:00 AM

Enzyme_Inhibitor copy.jpgThe development of novel enzyme inhibitors has led to effective therapeutic options for diseases that were once considered difficult to treat. A newly updated study by BCC Research finds that approvals of new molecular entities will drive the global market for enzyme inhibitors to $179.9 billion by 2022. Enzyme inhibitors offer therapeutic options for myriad illnesses, including HCV, HIV, cancer, gastrointestinal disease, cardiovascular disease, inflammatory disorders, rheumatoid arthritis, neurological disorders (depression, Parkinson’s disease, Alzheimer’s disease) and diabetes.

Read More

Topics: Life Sciences, Biotechnology

NRAM –  Riddle, Wrapped in a Mystery, Inside an Enigma Machine

Posted by Chris Spivey on Jan 10, 2018 1:55:22 PM

Image_NRAMBlog.jpgWhat amazed historians about the fall of the USSR, was that it had stayed together so long. The same can be said of Nantero.

Read More

Continuous Glucose Monitoring Finds Sweet Spot Without the Sting

Posted by Laurie L. Sullivan on Jan 9, 2018 2:30:00 PM

Glucose Monitor.jpegThe continuous glucose monitoring market, introduced nearly 20 years ago, is presently experiencing strong growth as diabetics, physicians, hospitals and clinics witness the benefits these devices can lend to the management of glucose levels. The market now includes blood glucose monitors, diabetes test strips, insulin durable and patch pumps, glucose sensors, and transmitters and receivers. The global market for continuous glucose monitoring equipment is expected to top $20.6 billion by 2022, according to a new study by BCC Research, at a five-year compound annual growth rate (CAGR) of 10.1%.

Read More

Topics: Life Sciences, Healthcare